Infections of indwelling central venous catheters among patients treated with intravenous epoprostenol for pulmonary hypertension

D. O‘Callaghan, A. Moutet, X. Jais, F. Parent, L. Savale, D. Natali, A. Yaici, G. Simonneau, M. Humbert, F. Doucet-Populaire, O. Sitbon (Clamart, France)

Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Session: Pulmonary circulation: clinical aspects
Session type: E-Communication Session
Number: 5606
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. O‘Callaghan, A. Moutet, X. Jais, F. Parent, L. Savale, D. Natali, A. Yaici, G. Simonneau, M. Humbert, F. Doucet-Populaire, O. Sitbon (Clamart, France). Infections of indwelling central venous catheters among patients treated with intravenous epoprostenol for pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 5606

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 636s
Year: 2004

Surveillance of tunnelled central venous catheter infections in patients with pulmonary arterial hypertension (PAH) treated with i.v. iloprost
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Central venous catheter infections in out-patients with pulmonary hypertension treated with continuous iloprost
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Complications of a permanently implanted port system for continuous epoprostenol treatment in pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002

Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
Source: International Congress 2017 – NICU/ PICU: evaluating short- and long-term ventilatory management
Year: 2017


Antecubital venous access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Intravenous line complications during continuous iloprost therapy using directly inserted subclavian catheters
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009

Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 595-600
Year: 2004



Successful artocoronary bypass grafting in a patient with severe idiopathic pulmonary arterial hypertension: use of intravenous treprostinil
Source: Eur Respir J 2006; 28: Suppl. 50, 384s
Year: 2006

Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Therapeutic aspects of pulmonary embolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25
Year: 2004

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
Source: Eur Respir J 2006; 28: 1195-1203
Year: 2006



Experience with inhaled iloprost in paediatric pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011


Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019




Jugular venous ultrasound predicts outcomes in pulmonary hypertension outpatients
Source: Eur Respir J, 59 (1) 2102591; 10.1183/13993003.02591-2021
Year: 2022



Low dose intravenous iloprost therapy in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006

Physiological basis of monitoring with central venous and pulmonary artery catheters and their clinical use
Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients
Year: 2015




The COPD frequency in patients with venous thrombosis
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005

Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012